Department of Clinical Pharmacy and Pharmacy Administration, Obafemi Awolowo University, Ile-Ife, Nigeria.
Clin Drug Investig. 2003;23(9):583-90. doi: 10.2165/00044011-200323090-00004.
To gain insight into the control of hypertension and to suggest possible interventions within a selected black population treated with combination diuretics (amiloride 5mg + hydrochlorothiazide 50mg) and/or methyldopa for uncomplicated essential hypertension.
A 2-year retrospective cohort review of the outpatient medical records of a State Comprehensive Health Center in southwestern Nigeria. Free primary health service, including free drugs, is provided in the health facility for all patients.
The study population included outpatients continuously registered at the health centre between June 1999 and June 2002, aged >/=36 years, with 2-6 months' history of hypertension or newly diagnosed hypertension and followed for 6 months after diagnosis. They were managed with methyldopa 250mg and/or combination diuretics (amiloride 5mg + hydrochlorothiazide 50mg) or a combination in two different regimens for at least 6 months. Participating physicians measured patients' blood pressure with a validated device and recorded demographics and medical history. Patients were considered to have hypertension if systolic blood pressure was >140mm Hg and diastolic blood pressure was >90mm Hg.
Bivariate regression analysis revealed that systolic blood pressure contributed moderately to the variances of drug and regimen decisions. Among the 128 hypertensive patients with average and modal ages of 57.2 +/- 11.1 and 60 years, respectively, only 37.5% had controlled blood pressure after the first treatment; with 10.2% and 4% of the study population needing, respectively, three and five re-treatments within 6 months to achieve target blood pressure levels.
A high percentage of uncontrolled blood pressure and re-treatment rates were observed within the study population. A more aggressive management strategy that individualises diuretic therapy by titrating dose to systolic blood pressure and prioritises lifestyle modification in middle-aged and elderly black hypertensive patients is suggested.
深入了解高血压的控制情况,并针对接受复方利尿剂(阿米洛利 5mg+氢氯噻嗪 50mg)和/或甲基多巴治疗的特定黑人人群提出可能的干预措施,这些人群患有单纯性原发性高血压。
对尼日利亚西南部一家州综合保健中心的门诊医疗记录进行了为期 2 年的回顾性队列研究。该医疗设施为所有患者提供免费的初级卫生服务,包括免费药物。
研究人群包括 1999 年 6 月至 2002 年 6 月期间在该保健中心连续登记的门诊患者,年龄>/=36 岁,有 2-6 个月的高血压病史或新诊断的高血压病史,且在诊断后随访 6 个月。他们接受了甲基多巴 250mg 和/或复方利尿剂(阿米洛利 5mg+氢氯噻嗪 50mg)或两种不同方案的联合治疗,至少 6 个月。参与研究的医生使用经过验证的设备测量患者的血压,并记录人口统计学和病史。如果收缩压>140mmHg,舒张压>90mmHg,则认为患者患有高血压。
双变量回归分析显示,收缩压对药物和治疗方案决策的差异有中等程度的贡献。在 128 例平均年龄和模态年龄分别为 57.2+/-11.1 岁和 60 岁的高血压患者中,仅有 37.5%的患者在首次治疗后血压得到控制;研究人群中分别有 10.2%和 4%的患者需要在 6 个月内进行 3 次和 5 次再治疗才能达到目标血压水平。
在研究人群中,血压控制不佳和再治疗率较高。建议对中年和老年黑人高血压患者采取更积极的管理策略,通过滴定剂量至收缩压个体化利尿剂治疗,并优先进行生活方式改变。